Literature DB >> 27452297

Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

Keisaku Sato1, Chad Hall2, Shannon Glaser1, Heather Francis1, Fanyin Meng1, Gianfranco Alpini3.   

Abstract

Kupffer cells are the resident macrophages in the liver. They are located in hepatic sinusoid, which allows them to remove foreign materials, pathogens, and apoptotic cells efficiently. Activated Kupffer cells secrete various mediators, including cytokines and chemokines, to initiate immune responses, inflammation, or recruitment of other liver cells. Bile duct ligation (BDL) surgery in rodents is often studied as an animal model of cholestatic liver disease, characterized by obstruction of bile flow. BDL mice show altered functional activities of Kupffer cells compared with sham-operated mice, including elevated cytokine secretion and impaired bacterial clearance. Various mediators produced by other liver cells can regulate Kupffer cell activation, which suggest that Kupffer cells orchestrate with other liver cells to relay inflammatory signals and to maintain liver homeostasis during BDL-induced liver injury. Blocking or depletion of Kupffer cells, an approach for the treatment of liver diseases, has shown controversial implications. Procedures in Kupffer cell research have limitations and may produce various results in Kupffer cell research. It is important, however, to reveal underlying mechanisms of activation and functions of Kupffer cells, followed by hepatic inflammation and fibrosis. This review summarizes present Kupffer cell studies in cholestatic liver injury.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27452297      PMCID: PMC5012503          DOI: 10.1016/j.ajpath.2016.06.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  99 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).

Authors:  Rocio T Martinez-Nunez; Fethi Louafi; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

3.  Depletion of hepatic stellate cells: have Kupffer cells lost their bad neighbor?

Authors:  Ricardo Marcos
Journal:  J Hepatol       Date:  2014-06-02       Impact factor: 25.083

4.  Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice.

Authors:  Manabu Kinoshita; Takefumi Uchida; Atsushi Sato; Masahiro Nakashima; Hiroyuki Nakashima; Satoshi Shono; Yoshiko Habu; Hiromi Miyazaki; Sadayuki Hiroi; Shuhji Seki
Journal:  J Hepatol       Date:  2010-07-14       Impact factor: 25.083

5.  M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

Authors:  Jinghong Wan; Merieme Benkdane; Fatima Teixeira-Clerc; Stéphanie Bonnafous; Alexandre Louvet; Fouad Lafdil; Françoise Pecker; Albert Tran; Philippe Gual; Ariane Mallat; Sophie Lotersztajn; Catherine Pavoine
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

6.  Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice.

Authors:  Szabolcs Abrahám; Andrea Szabó; József Kaszaki; Renáta Varga; Katalin Eder; Erno Duda; György Lázár; László Tiszlavicz; Mihály Boros; György Lázár
Journal:  Shock       Date:  2008-07       Impact factor: 3.454

7.  Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats--analysis of mechanisms of lethality in endotoxemia.

Authors:  Y Iimuro; M Yamamoto; H Kohno; J Itakura; H Fujii; Y Matsumoto
Journal:  J Leukoc Biol       Date:  1994-06       Impact factor: 4.962

8.  Interleukin-1 participates in the progression from liver injury to fibrosis.

Authors:  Roben G Gieling; Karen Wallace; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

9.  A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation.

Authors:  Guoqing Zhuang; Cong Meng; Xin Guo; Patali S Cheruku; Lei Shi; Hang Xu; Honggui Li; Gang Wang; Ashley R Evans; Stephen Safe; Chaodong Wu; Beiyan Zhou
Journal:  Circulation       Date:  2012-05-11       Impact factor: 29.690

10.  Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.

Authors:  Michio Hara; Hiroshi Kono; Shinji Furuya; Kazuyoshi Hirayama; Masato Tsuchiya; Hideki Fujii
Journal:  J Surg Res       Date:  2013-03-28       Impact factor: 2.192

View more
  32 in total

1.  Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells.

Authors:  Nan Wu; Kelly McDaniel; Tianhao Zhou; Sugeily Ramos-Lorenzo; Chaodong Wu; Li Huang; Demeng Chen; Tami Annable; Heather Francis; Shannon Glaser; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-31       Impact factor: 4.052

Review 2.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

Review 3.  Mechanisms of bile acid mediated inflammation in the liver.

Authors:  Man Li; Shi-Ying Cai; James L Boyer
Journal:  Mol Aspects Med       Date:  2017-07-01

Review 4.  Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Lindsey Kennedy; Suthat Liangpunsakul; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2019-04-22       Impact factor: 6.902

Review 5.  Mechanisms of cholangiocyte responses to injury.

Authors:  Keisaku Sato; Fanyin Meng; Thao Giang; Shannon Glaser; Gianfranco Alpini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-23       Impact factor: 5.187

6.  [Effects of Panax notoginseng saponins on liver graft rejection in rats and the mechanisms].

Authors:  Xianbing Zhang; Xun Li; Ping Xiong; Chuanchao Yi; Xi Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

Review 7.  The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.

Authors:  Oraianthi Fiste; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Michalis Liontos; Konstantinos Koutsoukos; Meletios Athanasios Dimopoulos; Flora Zagouri
Journal:  Vaccines (Basel)       Date:  2021-04-22

Review 8.  The role of bile acids in cholestatic liver injury.

Authors:  Shi-Ying Cai; James L Boyer
Journal:  Ann Transl Med       Date:  2021-04

Review 9.  Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.

Authors:  Taek Chung; Young Nyun Park
Journal:  Front Med (Lausanne)       Date:  2022-03-31

Review 10.  The Functional Roles of Immune Cells in Primary Liver Cancer.

Authors:  Linh Pham; Konstantina Kyritsi; Tianhao Zhou; Ludovica Ceci; Leonardo Baiocchi; Lindsey Kennedy; Sanjukta Chakraborty; Shannon Glaser; Heather Francis; Gianfranco Alpini; Keisaku Sato
Journal:  Am J Pathol       Date:  2022-03-23       Impact factor: 5.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.